{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:19:47Z","timestamp":1783948787385,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1053\/j.seminhematol.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:48:18Z","timestamp":1744148898000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma"],"prefix":"10.1053","volume":"62","author":[{"given":"Alessandra","family":"Tedeschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Autore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe E.","family":"Gatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kimby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger G.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna","family":"Sarosiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Varettoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey V.","family":"Matous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Buske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon Garcia","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0001","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2025.04.002_bib0002","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/bjh.18002","article-title":"Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-waldenstrom macroglobulinemia type: a Swedish lymphoma registry study","volume":"196","author":"Brandefors","year":"2022","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1053\/j.seminhematol.2025.04.002_bib0003","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2025.04.002_bib0004","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.seminhematol.2025.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ajh.25600","article-title":"Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network","volume":"94","author":"Varettoni","year":"2019","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2025.04.002_bib0006","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/10428194.2020.1719100","article-title":"A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia","volume":"61","author":"Castillo","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1053\/j.seminhematol.2025.04.002_bib0007","first-page":"568","article-title":"Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]","volume":"43","author":"Yu","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1053\/j.seminhematol.2025.04.002_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2022.10.005","article-title":"Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms","volume":"130","author":"Qiu","year":"2022","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1053\/j.seminhematol.2025.04.002_bib0009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5045\/br.2018.53.3.189","article-title":"Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience","volume":"53","author":"Kang","year":"2018","journal-title":"Blood Res"},{"issue":"5","key":"10.1053\/j.seminhematol.2025.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3109\/10428194.2015.1096357","article-title":"Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression","volume":"57","author":"Cao","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1053\/j.seminhematol.2025.04.002_bib0011","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3324\/haematol.10755","article-title":"Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenstr\u00f6m's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance","volume":"92","author":"Mart\u00edn-Jim\u00e9nez","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2025.04.002_bib0012","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2141.2006.06397.x","article-title":"Functional class switch recombination may occur 'in vivo' in Waldenstr\u00f6m Macroglobulinaemia","volume":"136","author":"Mart\u00edn-Jim\u00e9nez","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0013","article-title":"Lymphoplasmacytic lymphoma with only Lambda light chain monoclonal paraprotein expression","volume":"9","author":"Cautha","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0014","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3892\/ol.2024.14471","article-title":"Good clinical response following Ibrutinib treatment of a rare case of lymphoplasmacytic lymphoma secreting IgA kappa paraprotein: a case report","volume":"28","author":"Nikolova","year":"2024","journal-title":"Oncol Lett"},{"issue":"9","key":"10.1053\/j.seminhematol.2025.04.002_bib0015","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2014.108688","article-title":"Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma","volume":"99","author":"Hamadeh","year":"2014","journal-title":"Haematologica"},{"issue":"20","key":"10.1053\/j.seminhematol.2025.04.002_bib0016","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2025.04.002_bib0017","first-page":"105","article-title":"Screening panels for monoclonal gammopathies: time to change","volume":"30","author":"Katzmann","year":"2009","journal-title":"Clin Biochem Rev"},{"issue":"10","key":"10.1053\/j.seminhematol.2025.04.002_bib0018","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1515\/cclm-2016-0748","article-title":"Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression","volume":"55","author":"Andrade-Campos","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"20","key":"10.1053\/j.seminhematol.2025.04.002_bib0019","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1158\/1078-0432.CCR-15-2899","article-title":"IgM\u03ba and IgM\u03bb measurements for the assessment of patients with Waldenstr\u00f6m's macroglobulinaemia","volume":"22","author":"Boyle","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2025.04.002_bib0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/cclm-2020-0581","article-title":"Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab","volume":"59","author":"Kohlhagen","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2025.04.002_bib0021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41408-021-00444-0","article-title":"MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients","volume":"11","author":"Mellors","year":"2021","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1053\/j.seminhematol.2025.04.002_bib0022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41408-023-00944-1","article-title":"Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study","volume":"13","author":"P\u00e9rez-Escurza","year":"2023","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1053\/j.seminhematol.2025.04.002_bib0023","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/leu.2013.124","article-title":"Multiparameter flow cytometry for the identification of the Waldenstr\u00f6m's clone in IgM-MGUS and Waldenstr\u00f6m's macroglobulinemia: new criteria for differential diagnosis and risk stratification","volume":"28","author":"Paiva","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2025.04.002_bib0024","doi-asserted-by":"crossref","unstructured":"Jimenez C, Carmen Chillon MD, Balanzategui A, et al. Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction. 2014 2014;doi:10.1097\/PAI.0000000000000020","DOI":"10.1097\/PAI.0000000000000020"},{"issue":"5","key":"10.1053\/j.seminhematol.2025.04.002_bib0025","article-title":"MYD88L265P Detection in IgM monoclonal gammopathies: methodological considerations for routine implementation","volume":"11","author":"Ferrante","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"10.1053\/j.seminhematol.2025.04.002_bib0026","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstr\u00f6m's macroglobulinemia","volume":"27","author":"Jim\u00e9nez","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"10.1053\/j.seminhematol.2025.04.002_bib0027","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcp\/aqw072","article-title":"Lymphoplasmacytic lymphoma with a non-IgM paraprotein shows clinical and pathologic heterogeneity and may harbor MYD88 L265P mutations","volume":"145","author":"King","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1053\/j.seminhematol.2025.04.002_bib0028","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000530100","article-title":"Waldenstr\u00f6m macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar","volume":"146","author":"Awata-Shiraiwa","year":"2023","journal-title":"Acta Haematol"},{"issue":"7","key":"10.1053\/j.seminhematol.2025.04.002_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071541","article-title":"Time to move to the single-cell level: applications of single-cell multi-omics to hematological malignancies and Waldenstr\u00f6m's macroglobulinemia-a particularly heterogeneous lymphoma","volume":"13","author":"Garc\u00eda-Sanz","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.seminhematol.2023.03.007","article-title":"Report of Consensus Panel 3 from the 11th International workshop on Waldenstr\u00f6m's macroglobulinemia: recommendations for molecular diagnosis in Waldenstr\u00f6m's macroglobulinemia","volume":"60","author":"Garcia-Sanz","year":"2023","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0031","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41375-022-01762-3","article-title":"Diagnostics in Waldenstr\u00f6m's macroglobulinemia: a consensus statement of the European Consortium for Waldenstr\u00f6m's macroglobulinemia","volume":"37","author":"Dogliotti","year":"2023","journal-title":"Leukemia"},{"issue":"6","key":"10.1053\/j.seminhematol.2025.04.002_bib0032","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.2017.186528","article-title":"Highly sensitive MYD88(L265P) mutation detection by droplet digital polymerase chain reaction in Waldenstr\u00f6m macroglobulinemia","volume":"103","author":"Drandi","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0033","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/sonc.2003.50038","article-title":"Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia","volume":"30","author":"Kyle","year":"2003","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2025.04.002_bib0034","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1506192","article-title":"MYD88 Mutations and response to Ibrutinib in Waldenstr\u00f6m's macroglobulinemia","volume":"373","author":"Treon","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2025.04.002_bib0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.20.00555","article-title":"Long-term follow-up of Ibrutinib monotherapy in symptomatic, previously treated patients with Waldenstr\u00f6m macroglobulinemia","volume":"39","author":"Treon","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.seminhematol.2023.03.005","article-title":"Report of consensus panel 1 from the 11(th) International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-na\u00efve patients","volume":"60","author":"Buske","year":"2023","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0037","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.hoc.2023.12.016","article-title":"Proteasome inhibitors in multiple myeloma: biological insights on mechanisms of action or resistance informed by functional genomics","volume":"38","author":"Mitsiades","year":"2024","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1053\/j.seminhematol.2025.04.002_bib0038","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2016-09-742411","article-title":"BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years","volume":"129","author":"Gavriatopoulou","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2025.04.002_bib0039","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2014-03-566273","article-title":"Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstr\u00f6m's macroglobulinemia","volume":"124","author":"Treon","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2025.04.002_bib0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.21.00105","article-title":"Combining Ixazomib with subcutaneous Rituximab and Dexamethasone in relapsed or refractory Waldenstr\u00f6m's macroglobulinemia: final analysis of the phase I\/II HOVON124\/ECWM-R2 study","volume":"40","author":"Kersten","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2025.04.002_bib0041","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2015-01-553974","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"126","author":"Treon","year":"2015","journal-title":"Blood"},{"issue":"S1","key":"10.1053\/j.seminhematol.2025.04.002_bib0042","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5045\/br.2022.2022054","article-title":"Treatment of indolent lymphoma","volume":"57","author":"Jeong","year":"2022","journal-title":"Blood Res"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0043","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminhematol.2023.03.009","article-title":"Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria","volume":"60","author":"Treon","year":"2023","journal-title":"Semin Hematol"},{"issue":"27","key":"10.1053\/j.seminhematol.2025.04.002_bib0044","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1053\/j.seminhematol.2025.04.002_bib0045","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","article-title":"Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy","volume":"128","author":"Cheson","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2025.04.002_bib0046","doi-asserted-by":"crossref","unstructured":"Pan Q., Luo Y., Zhang Y., et al. Preliminary evidence of imaging of chemokine receptor-4-targeted PET\/CT with [EJNMMI res. 2020;10(1):89. doi:10.1186\/s13550-020-00681-7","DOI":"10.1186\/s13550-020-00681-7"},{"issue":"2","key":"10.1053\/j.seminhematol.2025.04.002_bib0047","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.12102","article-title":"Response assessment in Waldenstr\u00f6m macroglobulinaemia: update from the VIth International Workshop","volume":"160","author":"Owen","year":"2013","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2025.04.002_bib0048","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196325000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196325000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T13:22:40Z","timestamp":1750857760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196325000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0037196325000125"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2025.04.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}